Logout
Do you want to be automatically logged in from this computer, the next time you visit us?

Click to Join or Renew Your Membership

ICH 2010 Workshop Washington D.C., USA

Click to see Hotel InformationICH 2010 Washington

Click to see Hotel InformationHotel and Area Information

Click to see Fees and RegistrationFees and Registration

Click to see ICH 2010 OverviewICH 2010 Overview

 

Workshop Hotel

Bethesda North Marriott
+1-301-822-9200
www.bethesdanorthmarriott.com

Click to RegisterRegulatory Registration Full Graphic

Don’t Miss this Unique Opportunity in North America

Event dates and times

6 October 13.00 – 18.00

7 October 08.30 – 18.10

8 October 08.30 – 13.00

There will be a networking reception on Wednesday at 18.30.

Building on the success of the European event, this North America ICH Workshop brings a unique opportunity for industry-regulator learning and interaction. Attendees will not only hear directly from the industry and regulator experts who developed the ICH guidelines and learn from case studies, but spend an entire day in small group workshops where industry and regulatory attendees will be able to have effective discussions. Join around 200 regulators in discussion breakouts addressing Design Space, Control Strategy, Pharmaceutical Quality System, and Quality Risk Management. Feedback from these sessions will be presented on the final day and delivered to the ICH working group to assist with the implementation of the new ICH guidelines. A major concluding feature will be the opportunity to put all your questions to a distinguished panel of Expert Working Group representatives.

**Workshop attendees will rotate through all four (4) discussion breakouts. Companies may wish to send multiple registrants for the most effective participation.

This is a unique Opportunity for Open Dialogue among Industry and Regulators

  • Create shared understanding and influence how ICH Q8, Q9 and Q10 can be implemented by taking part in the dialogues that will shape the future of our industry and those who regulate it.
  • Hear first-hand from ICH Expert Working Group members.
  • Interact with over 150 FDA representatives together with regulators from Europe, Canada, China and other regions.
  • Share experiences with industry and regulatory representatives in a highly-interactive format.
  • Address and build upon conclusions from the European ICH event.

Case Studies and Discussion Topics

Case Studies Presenters
How ICH Guidelines are Working Together throughout the Product Lifecycle Moheb Nasr, FDA, Q-IQG
Product Development Jean Wyvratt, Merck
Regulatory Assessment Elaine Morefield, CDER, FDA
Implementation and PQS considerations Nigel Hamilton, Sanofi-Aventis
Inspections at a Manufacturing Site Jacques Morenas, AFSSAPS, France

 

Discussion Topics Presenters
Design Space Moheb Nasr, FDA and Georges France, Pfizer
Control Strategy Bob Baum, Pfizer and Jean-Louis Robert, Dept. QC of Medicines, Luxembourg
Pharmaceutical Quality System David Cockburn, EMA and Swroop Sahota, Merck
Quality Risk Management Stephan Rönninger, Roche and Diana Amador-Toro, ORA, FDA

 

Last Update: 14 October 2010